BiotechTube
Home/Whitehawk Therapeutics/CEO Placeholder
CP

CEO Placeholder

Chief Executive Officer

Whitehawk Therapeutics

Therapeutic Areas

OncologyImmuno-Oncology

Whitehawk Therapeutics Pipeline

DrugIndicationPhase
WHK-001Advanced Solid Tumors (including Recurrent Glioblastoma and NSCLC)Phase 1/2

Leadership Team at Whitehawk Therapeutics

CP
CSO Placeholder
Chief Scientific Officer
CP
CMO Placeholder
Chief Medical Officer
CP
CBO Placeholder
Chief Business Officer
VR
VP Research Placeholder
Vice President of Research
View full Whitehawk Therapeutics profile